Nyseamerican catx
Nov 24, 2023 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CATX shares currently have a short interest ratio of 2.0. Learn More on Perspective Therapeutics's short interest ratio. Detailed balance sheet for Perspective Therapeutics, Inc. (CATX), including cash, debt, assets, liabilities, and book value.
Did you know?
Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) was the target of a significant increase in short interest in October.As of October 31st, there was short interest totalling ...Company profile for Perspective Therapeutics, Inc. (CATX) with a description, list of executives, contact details and other key facts. ... NYSEAMERICAN: CATX · IEX ...What is it? The lowest level of National Environmental Policy Act (NEPA) analysis is that given to CATEXs (also called CX, CatEx, CatX, etc.). "Categorical exclusion" means a category of actions which do not individually or cumulatively have a significant effect on the human environment and which have been found to have no such effect in procedures …Oct 20, 2023 · In the previous quarter, Perspective Therapeutics (NYSEAMERICAN:CATX) missed the analysts' consensus estimate of -0.03 by 0.01 with a reported earnings per share (EPS) of -0.04. Learn more on analysts' earnings estimate vs. CATX's actual earnings. (NYSE AMERICAN: CATX), today announced the publication of four preclinical studies in support of the Company's discovery pipeline. The studies were ...Find real-time CATX - Perspective Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time CATX - Perspective Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Oct 5, 2023 · Perspective Therapeutics is the world’s only producer of Cesium-131 seeds for brachytherapy which provide expanding internal radiation treatment options throughout the body for prostate cancer ... The 1 analysts offering 12-month price forecasts for Perspective Therapeutics Inc have a median target of 1.20, with a high estimate of 1.20 and a low estimate of 1.20. The median estimate ... CATX's P/S is 38% below its last 4 quarters average of 13.9 but 24% above its 5-year quarterly average of 6.9 The revenue has declined by 18% year-on-year but it has increased by 6% since the previous quarter Perspective Therapeutics (CATX) Social Media Sentiment and Mentions. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get daily stock ideas from top-performing Wall Street analysts.Alpha Star Acquisition Co. (NASDAQ:ALSAW – Get Free Report) was the recipient of a large drop in short interest in July. As of July 31st, there was short interest totalling 1,000 shares, a drop ...Posted by MarketBeat News on Dec 4th, 2023. Hewlett Packard Enterprise ( NYSE:HPE – Get Free Report) was the recipient of a large increase in short interest in November. As of November 15th ...Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report)’s share price dropped 3.4% on Friday . The company traded as low as 0.61 and last traded at 0.61. Approximately 148,900 ...The stock was sold at an average price of $27.14, for a total value of $313,331.30. Following the transaction, the insider now owns 320,763 shares in the company, valued at approximately ...About NYSEAMERICAN:CATX Perspective Therapeutics Stock Price, News & Analysis (NYSEAMERICAN:CATX) 0.26 0.00 (-1.24%) (As of 11/22/2023 06:30 PM ET) Compare Today's Range 0.25 0.26 50-Day Range N/A 52-Week Range 0.21 0.73 Volume 121,100 shs Average Volume 603,052 shs Market Capitalization $71.55 million P/E Ratio N/A Dividend Yield N/ASEATTLE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- PerspectivZH Zhihu $1.03 CATX Perspective Therapeutics $0.51 LMF Nov 18, 2023 · Perspective Therapeutics Stock Up 0.5 %. CATX opened at 0.26 on Friday. The stock has a market capitalization of $73.00 million, a PE ratio of -2.60 and a beta of 1.70. Perspective Therapeutics ... Stock Exchange NYSEAMERICAN. Ticker Symbol ZOM. Full Company P Dec 1, 2023 · Perspective Therapeutics has a market cap or net worth of $72.95 million as of December 1, 2023. Its market cap has increased by 28.66% in one year. Market Cap. 72.95M. Enterprise Value. 58.09M. 1-Year Change. 28.66%. Ranking. Company profile for Perspective Therapeutics, Inc. (CATX) with
Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.Stock Exchange NYSEAMERICAN. Ticker Symbol JOB. Full Company Profile. Financial Performance. In 2022, GEE Group's revenue was $165.11 million, an increase of 10.90% compared to the previous year's $148.88 million. Earnings were $19.60 million, an increase of 326550.00%. Financial Statements. News. All;Perspective Therapeutics Inc (NYSE American:CATX). 0.2571. Delayed Data. As of Nov 30. +0.0021 / +0.82%. Today's Change. 0.21. Today|||52-Week Range. 0.73. + ...Details . The Basics; Length of Returned Variable; Length of Returned Variable: Special Cases; The Basics. The CATX function first copies item-1 to the result, omitting leading and trailing blanks. Next, for each subsequent argument item-i, i=2, …, n, if item-i contains at least one non-blank character, CATX appends delimiter and item-i to …NYSE American, formerly known as the American Stock Exchange (AMEX), and more recently as NYSE MKT, is an American stock exchange situated in New York City.AMEX was previously a mutual organization, owned by its members.Until 1953, it was known as the New York Curb Exchange.. NYSE Euronext acquired AMEX on October 1, 2008, with …
A high-level overview of Perspective Therapeutics, Inc. (CATX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Balance Sheet. Stock analysis for Perspective Therapeutics Inc (CATX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Stock analysis for Battalion Oil Corp (BATL:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Rep. Possible cause: Oct 11, 2023 · Perspective Therapeutics, Inc. ( NYSEAMERICAN:CATX – G.
The CATX function returns a value to a variable, or returns a value in a temporary buffer. The value that is returned from the CATX function can be up to 32767 characters, except in WHERE clauses. If the length of the variable or the buffer is not large enough to contain the result of the concatenation, SAS truncates the result.CATX Perspective Therapeutics Inc stock NYSEAMERICAN. Market Open. 5/23/2023 12:07:30 PM EDT. 0.5115 USD +0.294 % (+0.0015) 33,249. 0.4692 Bid 0.5458 Ask 0.0766 ...
RICHLAND, & CORALVILLE, IOWA, June 27, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (Perspective or the Company) (NYSE AMERICAN: CATX), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed brachytherapy ... VMT--NET for neuroendocrine cancers and VMT01 ... Perspective Therapeutics (CATX) delivered earnings and revenue surprises of -33.33% and 20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Fastenal ( NASDAQ:FAST – Get Free Report) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 16,760,000 shares ...
Stock Exchange NYSEAMERICAN. Ticker Symbol CEI. Full USAF’s Preliminary B-21 Flight Falls Behind Schedule, but Only Slightly. Posted by Keala Milles on Mar 22nd, 2023 . It is a few months late, but the United States Air Force’s new B-21 Raider ... Stock analysis for Ivanhoe Electric Inc / US (IE:NYSEAmerican) incCATX News. 1 day ago - Perspective Therapeut Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report)’s share price dropped 3.4% on Friday . The company traded as low as 0.61 and last traded at 0.61. Approximately 148,900 ... We would like to show you a description here but the site 28 ឧសភា 2023 ... Headquartered in Richland, Washington, Perspective Therapeutics (NYSEAMERICAN:CATX) bills itself as a developer of game-changing therapies ...Get the latest NYSE American Composite Index (XAX) value, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Nov 29, 2023 · Interactive stock price cInteractive stock price chart for Perspective TherapeuDec 4, 2023 · As of November 15th, there was 1.93%. $125.46B. CATX | Complete Perspective Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.USAF’s Preliminary B-21 Flight Falls Behind Schedule, but Only Slightly. Posted by Keala Milles on Mar 22nd, 2023 . It is a few months late, but the United States Air Force’s new B-21 Raider ... For those who laugh in the face of extreme finan Explore Perspective Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 28 news, Disease Domain:Neoplasms, Technology Platform:Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC), Synthetic peptide, Radiopharmaceuticals and diagonstic agent, Therapeutic radiopharmaceuticals, Drug:[203Pb]VMT01, [212Pb] VMT 01 (Viewpoint Molecular ...Total Valuation. CATX has a market cap or net worth of $72.61 million. The enterprise value is $57.75 million. Market Cap. 72.61M. Enterprise Value. 57.75M. The Nasdaq and the NYSE American (formerly AMEX) are two ways to tr[EX-99.1 ex_600497.htm EXHIBIT 99.1. ex_600497.htm. SEATTLE – NovemberAccording to 2 stock analysts, the average 12-m The 1 analysts offering 12-month price forecasts for Perspective Therapeutics Inc have a median target of 1.20, with a high estimate of 1.20 and a low estimate of 1.20. The median estimate ...